Anandron and confusional state Patient Reports February 12, 2012

Anandron Side Effects Report #5098037-5
Anandron side effect was reported by a Consumer or non-health professional from on Aug 30, 2006. Male patient, 80 years of age, weighting 110.2 lb, was diagnosed with prostate cancer metastatic and was treated with Anandron. After drug was administered, patient experienced the following side effects: asthenia, confusional state, hypocalcaemia, hypokalaemia, malignant neoplasm progression. Anandron dosage: unknown. During the same period patient was treated with CLASTOBAN, ENANTONE. Patient recovered.